Planta Med 2000; 66(6): 521-525
DOI: 10.1055/s-2000-11202
Original Paper
Georg Thieme Verlag Stuttgart · New York

Improvement of Phase I Drug Metabolism with Schisandra chinensis Against CCl4 Hepatotoxicity in a Rat Model

Min Zhu1,*, Rahael Y. Yeung1 , Kim F. Lin1 , Ronald C. Li1, 2
  • 1 Department of Pharmacy, The Chinese University of Hong Kong, Hong Kong
  • 2 Pharmacokinetic/Pharmacodynamic Sciences, Genetics Institute, Andover, MA, USA
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Abstract

The seed extract of Schisandra chinensis was investigated in the rat for its restorative or therapeutic effect on Phase I hepatic drug metabolism following intoxication by carbon tetrachloride (CCl4). Male Sprague Dawley rats (220 - 250 g) were divided into two sets, one included rats with or without CCl4 intoxication, the other included CCl4 intoxicated rats with or without treatment of Schisandra extract. With the treatment regimen, rats received four oral doses of Schisandra (160 mg/kg) or the same volume of water at 8, 24, 32 and 48 h after CCl4 intoxication. A single oral dose (80 mg/kg) of antipyrine, a conventional probe for oxidative drug metabolism, was then administered. The levels of liver serum transaminases and cytochrome P450 were measured and the pharmacokinetics of antipyrine were assessed using a non-compartmental approach via WinNonlin. In comparison to the rats without CCl4 intoxication (t1/2: 2.2 ± 0.9 h; Cl/F: 0.30 ± 0.01 L/h/Kg; P450: 0.611 ± 0.190 nmol/mg protein), CCl4 administration significantly decreased elimination (t1/2: 12.0 ± 3.9 h) and oral clearance (Cl/F: 0.049 ± 0.018 L/h/kg) of antipyrine, and markedly reduced the content of P450 (0.075 ± 0.011 nmol/mg protein). Data obtained from intoxicated animals treated by Schisandra extract, compared to those without treatment, showed significant (p < 0.05) improvement in the t1/2 (4.45 ± 1.7 h) and Cl/F (0.096 ± 0.018 ml/h) estimates of antipyrine and a 2 - 3 fold increase in P450 level (0.190 ± 0.072 nmol/mg protein). Findings in this study suggest that the seed extract of Schisandra appeared to be a promising agent for the improvement of Phase I oxidative metabolism in the liver damaged by CCl4.

References

  • 1 Lloyd  Y Y,, Kinble  M.. Applied Therapeutics: The Clinical Use of Drugs, 6th edition,. Vancouver,; Applied Therapeutics Inc., 1999;: 25-6
  • 2 Anonymous.. Pharmacopoeia of the People's Republic of China, English edition,. Guangzhou,; Guangdong Science and Technology Press, 1992;: 82-3
  • 3 Ko  K M,, Ip  S P,, Poon  M KT,, Wu  S S,, Che  C T,, Ng  K H,, Kong  Y C.. Effect of a lignan-enriched Fructus Schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachloride toxicity.  Planta Medica. 1995;;  61 134-7
  • 4 Tong  Q.. Deuteration of dimethyl 4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate (BDD): a remedy for chronic hepatitis.  Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae. 1990;;  12 42-5
  • 5 Ip  S P,, Poon  M KT,, Wu  S S,, Che  C T,, Ng  K H,, Kong  Y C,, Ko  K M.. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Medica. 1995;;  61.  398-401
  • 6 Chen  Y Y,, Shu  Z B,, Li  L N.. Studies on Fructus Schizandrae IV: isolation and determination of the active compounds (in lowering high SGPT levels) of Schizandra chinensis Baill.  Scientica Sinica. 1976;;  19 276-90
  • 7 Liu  C S,, Fang  S D,, Huang  M F,, Kao  Y L,, Hsu  J S.. Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds.  Scientia Sinica. 1978;;  21 483-502
  • 8 Liu  K T,, Lesca  P.. Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids.  Chemico-Biological Interactions. 1982;;  41 39-47
  • 9 Zhang  T M,, Wang  B E,, Liu  G T.. Effect of schisandrin B on lipoperoxidative damage to plasma membrane of rat liver in vitro.  Acta Pharmacology Sinica. 1992;;  13 255-8
  • 10 Zhu  M,, Lin  K F,, Yeung  R Y,, Li  R C.. Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model.  Journal of Ethnopharmacology. 1999;;  67 61-8
  • 11 Bao  T T.. Chung Hua I Hsueh Zazhi, 5, 275 - 278. Bao TT, Liu GT, Song ZY, Xu GF, Sun RH. A comparison of the pharmacologic actions of 7 constituents isolated from fructus schizandrae.  Chinese Medical Journal. 1980;;  93 41-7
  • 12 Reitmann  S,, Frankel  S.. A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases.  American Journal of Clinical Pathology. 1957;;  28 56-63
  • 13 Omura  T,, Sato  R.. The carbon monoxide-binding pigment of liver microsomes.  Journal of Biology and Chemistry. 1964;;  239 2370-8
  • 14 Eichelbaum  M,, Ochs  H R,, Robertz  G M,, Somogyl  A.. Pharmacokinetics and metabolism of antipyrine after intravenous and oral administration.  Arzneimittelforschung. 1982;;  32 575-8
  • 15 Engel  G,, Cosme  J.. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine formation.  Clinical pharmacology & therapeutics. 1996;;  59 613-22
  • 16 Ip  S P,, Ko  K M.. The crucial antioxidant action of schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene.  Biochemistry and Pharmacology. 1996;;  52 1687-93
  • 17 Kubo  S,, Ohkura  Y,, Mizoguchi  Y,, Matsui-Yuasa  I,, Otani  S,, Morisawa  S, et al.. Effect of gomisin A (TJN-101) on liver regeneration.  Planta Medica. 1992;;  58 489-92
  • 18 Lu  H,, Liu  G T.. Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae.  Planta Medica. 1992;;  58 311-3
  • 19 Zhai  H B,, Cong  P Z.. Mass spectrometric studies on dibenzocylclooctadiene lignan compounds from Schisandraceae plants.  Yao Hsueh Hsueh Pao (Acta Pharmaceutica Sinica). 1990;;  25 110-22
  • 20 He  X G,, Lian  L Z,, Lin  L Z.. Analysis of lignan constituents from Schisandra chinensis by liquid chromatography-electrospray mass spectrometry.  Journal of Chromatography A. 1997;;  757 81-7
  • 21 Tong  Y Y,, Song  W Z.. Determination of lignans in the fruits of Schisandra chinensis (Trucz.) Baill. and S. Sphenanthern Rehd. et Wils. using HPLC and their chromatograms.  Chung-Kuo Chung Yao Tsa Chih (Journal of Chinese Materia Medica). 1989;;  14 611-40
  • 22 Wang  K,, Tong  Y Y,, Song  W Z.. Determination of the active ingredients in Chinese drug wuweizi (Schisandra chinensis) by TLC-densitometry.  Yao Hsueh Hsueh Pao (Acta Pharmaceutica Sinica). 1990;;  25 49-53

D. Ph. Ronald C. Li

Pharmacokinetic/Pharmacodynamic Sciences

Genetics Institute

One Burtt Road

Andover

MA 01810

USA

Email: rcli@genetics.com

Phone: 1-978-247-1389